Search

The article focuses on a study in Germany regarding the development of three-dimensional (3-D) retina organoids, which could mimic the tissue organization of an organ. Topics discussed include the comment of biologist Mike Karl on their goal to create and study retina tissue, the potential of stem cell technologies in developing therapies, and the studies related to pluripotent stem cells.

The article offers information on the various types of stem cell therapies to manage corneal diseases. Topics include the origin and features of mammalian stem cells, the kinds of stem cell potency including pluripotent, totipotent or omnipotent, and multi-potent and their description, and ocular stem cells. The management of ocular diseases using stem cell therapy like cell replacement therapy is discussed.

The article reports on a study that utilized the pluripotent stem cell technology to correct a rare inherited eye disease called gyrate atrophy and develop therapies that reverses blindness caused by macular degeneration in the U.S.

The article focuses on several research related to graphene-based composite materials, induction of pluripotent stem cells, and semiempirical generalized gradient approximation (GGA) type density functional. Topics include graphene-based composite materials by Rodney S. Ruoff and others; induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by Kazutoshi Takahashi and others, and semiempirical GGA-type density functional by Stefan Grimme and colleagues.

The article discusses the research on the treatment of low vision patients including telescopic intraocular lenses (IOL) and harvested stem cells. Topics include the use of pluripotent stem cells in the treatment of macular degeneration, retinal pigment epithelium (RPE) stem cells, and the Argus II Retinal Prosthesis System attached to the retinal surface.

The article discusses the undergraduate optometry dissertation of Luqmaan Hafiz on stem cell therapy. Topics included are the recognition awarded by the journal and City University to the optometrist, the review of ocular stem cell therapy progression from animal models to clinical trials, and the pluripotent and multipotent classifications of the cells. The potential of induced pluripotent stem cells for use in ocular therapy is also discussed.

The article presents a case study of a Japanese women suffering with age-related macular degeneration (AMD) was grafted with retinal pigment epithelium cells sheet of 1.3mm x 3.0mm thickness. The epithelium sheet was developed using pluripotent stem cells, which has the potential to differentiate into any type of cell in the Human body. A section gives information on Schlemm's canal epithelial cells of glaucomatous eyes. INSET: 'Gatekeeper Cells' are Stifter in Eyes with Glaucoma.

The article presents a study which reveals that non-embryonic human stem cells could be applied to treat or cure age-related macular degeneration (AMD). It notes that the discovery of human-induced pluripotent stem (hiPS) cells may allow researchers to utilize a patient's stem cells to produce retinal tissues and cells for transplantation. Professor Nady Golestaneh discusses the production of hiPS-retinal pigment epithelium (RPE) cells.